Huadong Medicine Co., Ltd.: all 62 studies

Page 1 of 1. Open to participants first (46), then studies with results posted, then the rest; newest registration first within each.

• A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney DiseaseNot yet recruitingNCT07848880Phase 2
• A Study of HDM2017 Combination Therapy in Advanced Colorectal CancerRecruitingNCT07805551Phase 1/2
• A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) TherapyNot yet recruitingNCT07794397Phase 3
• A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) TherapyNot yet recruitingNCT07787260Phase 3
• HDM2005 Combination Therapy in Relapsed/Refractory Mantle Cell LymphomaNot yet recruitingNCT07697339Phase 1
• A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe HypertriglyceridemiaNot yet recruitingNCT07693777Phase 3
• Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic DermatitisNot yet recruitingNCT07683806Phase 3
• A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe HypertriglyceridemiaNot yet recruitingNCT07680829Phase 3
• A Study of HDM2020 in Patients With Advanced Sq-NSCLCRecruitingNCT07638891Phase 1
• A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal CancerNot yet recruitingNCT07621159Phase 1/2
• A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy SubjectsRecruitingNCT07594847Phase 1
• A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy ParticipantsNot yet recruitingNCT07559240Phase 1
• A Study of HDM2024 in Participants With Advanced Solid TumorsRecruitingNCT07539285Phase 1
• Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple MyelomaRecruitingNCT07529782Phase 1
• Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without DiabetesRecruitingNCT07521631Phase 2
• Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and DigoxinNot yet recruitingNCT07502001Phase 1
• A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorNot yet recruitingNCT07417306Phase 3
• A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneRecruitingNCT07394114Phase 3
• A Study of HDM2006 in Patients With Advanced Solid TumorRecruitingNCT07377591Phase 1
• A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and WarfarinRecruitingNCT07331389Phase 1
• Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without DiabetesRecruitingNCT07279194Phase 3
• A Phase 1 Study of HDM2017 in Advanced Solid TumorsRecruitingNCT07274085Phase 1
• Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic ControlRecruitingNCT07244003Phase 4
• Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingNCT07193459Phase 3
• A Study to Evaluate the Safety and Effectiveness of Kytogen Defend in Facial Skin Quality Improvement in Adult ParticipantsNot yet recruitingNCT07179198Not applicable
• A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell LymphomaRecruitingNCT07124936Phase 1/2
• Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseNot yet recruitingNCT07116928Phase 4
• A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or MetforminRecruitingNCT07109700Phase 2
• A Study of HDM2012 in Patients With Advanced Solid TumorRecruitingNCT07100249Phase 1
• A Study of HDM2020 in Patients With Advanced Solid TumorsRecruitingNCT07098052Phase 1
• A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingNCT07082114Phase 3
• Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal CancerRecruitingNCT07056777Phase 1/2
• Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese PatientsRecruitingNCT07036172Phase 3
• A Study of HDM2005 in Patients With Advanced Solid TumorRecruitingNCT07004296Phase 1
• A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic ImpairementRecruitingNCT06985615Phase 1
• Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes MellitusRecruitingNCT06886126Phase 2
• Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese AdultsNot yet recruitingNCT06885021Phase 3
• A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid TumorRecruitingNCT06615193Phase 1
• A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy SubjectsNot yet recruitingNCT06608329Phase 1
• A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.Not yet recruitingNCT06601517Phase 1
• A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy SubjectsRecruitingNCT06576401Phase 1
• HDM1002 Tablets in Chinese Overweight and Obese Adult SubjectsNot yet recruitingNCT06520540Phase 1
• Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese AdultsNot yet recruitingNCT06500299Phase 2
• A Study to Evaluate the Safety and Effectiveness of Injectable Gel for Correction of Infraorbital Hollowing in Chinese PopulationRecruitingNCT06394076Not applicable
• A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour DeficitNot yet recruitingNCT06391580Not applicable
• Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT06132828Phase 1
• A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624CompletedNCT05378893Phase 1Results posted
• A Pharmacokinetic Study of HDM1005 Injection at Different Injection SitesActive, not recruitingNCT07828197Phase 1
• A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis SubjectsCompletedNCT07357831Phase 3
• Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD SubjectsActive, not recruitingNCT07024212Phase 2
• Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 DiabetesCompletedNCT06739044Phase 3
• Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 StudyCompletedNCT06648772Phase 3
• Phase Ia Clinical Study of HDM1005 InjectionCompletedNCT06640647Phase 1
• Phase Ib Clinical Study of HDM1005 InjectionCompletedNCT06637020Phase 1
• Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.CompletedNCT06634927Phase 1
• Efficacy and Safety of Roflumilast Cream in Subjects With Atopic DermatitisCompletedNCT06631170Phase 3
• A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy SubjectsStatus unknownNCT06562088Phase 1
• A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe HypertriglyceridemiaCompletedNCT06555640Phase 2
• To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusCompletedNCT06481085Phase 2
• A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese ParticipantsCompletedNCT05943977Phase 3
• A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid TumorsTerminatedNCT05639153Phase 1
• A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian CancerStatus unknownNCT05622890Phase 3

← Huadong Medicine Co., Ltd. overview and focus areas